Bimatoprost versus travoprost in an egyptian population: A Hospital-based prospective, randomized study

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 6, 2010, Pages 605-610

  MacKy, Tamer A ^a,b  

^a Cairo University   (Egypt)

^b Al Nour Eye Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; TRAVOPROST;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EGYPT; EYE DISEASE; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OCULAR REDNESS; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TONOMETRY; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; EGYPT; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES;

EID: 78649719512     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0068     Document Type: Article

References (15)

1. Heijl, A., Leske, M.C., Bengtsson, B., et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch. Ophthalmol. 120:1268-1279, 2002.
2. Higginbotham, E.J., Schuman, J.S., Goldberg, I., et al. Bima-toprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch. Ophthalmol. 120:1286-1293, 2002.
3. Noecker, R.S., Dirks, M.S., Choplin, N.T., et al. Bimatoprost/Latanoprost Study Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am. J. Ophthalmol. 135:55-63, 2003.
4. Gandolfi, S., Simmons, S.T., Sturm, R., Chen, K., and Van-Denburgh, A.M. Bimatoprost Study Group 3. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv. Ther. 18:110-121, 2001.
5. Simmons, S.T., Dirks, M.S., and Noecker, R.J. Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Adv. Ther. 21:247-262, 2004.
6. Brubaker, R.F. Mechanism of action of bimatoprost (Lumi-ganTM). Surv. Ophthalmol. 45(Suppl 4):S347-351, 2001.
7. Netland, P.A., Landry, T., Sullivan, E.K., et al. Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am. J. Ophthalmol. 132:472-484, 2001.
8. Orengo-Nania, S., Landry, T., Von Tress, M., et al. Travoprost Study Group. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am. J. Ophthalmol. 132:860-868, 2001.
9. Parrish, R.K., Palmberg, P., and Sheu, W.P. XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am. J. Oph-thalmol. 135:688-703, 2003.
10. Noecker, R.J., Earl, M.L., Mundorf, T., Peace, J., and Williams, R.D. Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension. Adv. Ther. 20:121-128, 2003.
11. Noecker, R.J., Earl, M.L., Mundorf, T.K., Silverstein, S.M., and Phillips, M.P. Comparing bimatoprost and travoprost in black Americans. Curr. Med. Res. Opin. 22:2175-2180, 2006.
12. Sherwood, M., and Brandt, J. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv. Ophthalmol. 45(Suppl 4):S361-S368, 2001.
13. Cantor, L.B., Hoop, J., Morgan, L., Wudunn, D., and Catoira, Y. Bimatoprost-Travoprost Study Group. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Br. J. Ophthalmol. 90:1370-1373, 2006.
14. Cantor, L.B., WuDunn, D., Cortes, A., Hoop, J., and Knotts, S. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Surv. Ophthalmol. 49 Suppl 1:S12-S18, 2004.
15. Abelson, M.B., Mroz, M., Rosner, S.A., Dirks, M.S., and Hir-abayashi, D. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension. Adv. Ther. 20:1-13, 2003.